US · Healthcare

Cryomass Technologies Inc (CRYM)

Drug Manufacturers - Specialty & Generic

Cryomass Technologies Inc (CRYM) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CRYM

P/E ratio

18.00

Cryomass Technologies Inc (CRYM) — FAQ

What is CRYM's P/E ratio?

The price-to-earnings (P/E) ratio for Cryomass Technologies Inc (CRYM) is 18.00 (data as of 2026-03-24).

Does Cryomass Technologies Inc pay a dividend?

Dividend yield is not available in the current snapshot for Cryomass Technologies Inc (CRYM). Check the MyAverix Finance app for the latest dividend data.

What sector is Cryomass Technologies Inc in?

Cryomass Technologies Inc (CRYM) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is CRYM listed on?

CRYM is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)